Bernett, Matthew J <br/><br/>
Immune suppression in cynomolgus monkeys by XPro9523: an improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn.  [electronic resource] 

 -  mAbs   
 - 384-96 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1942-0870 
<br/><br/><label>Standard No.: </label>10.4161/mabs.23976  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Animals<br/>Antibody Affinity<br/>Antibody Formation--drug effects<br/>Arthritis, Experimental--therapy<br/>Arthritis, Rheumatoid--therapy<br/>B7-1 Antigen--immunology<br/>B7-2 Antigen--immunology<br/>Cells, Cultured<br/>Female<br/>Graft Rejection--therapy<br/>Histocompatibility Antigens Class I--immunology<br/>Humans<br/>Immunoconjugates--genetics<br/>Immunosuppression Therapy<br/>Kidney Transplantation<br/>Lymphocyte Activation--drug effects<br/>Macaca fascicularis<br/>Male<br/>Mice<br/>Mice, Inbred DBA<br/>Mutation--genetics<br/>Protein Binding--drug effects<br/>Protein Engineering<br/>Receptors, Fc--immunology<br/>Recombinant Fusion Proteins--genetics<br/>Structure-Activity Relationship